Concourse Financial Group Securities, Inc. Aclarion, Inc. Transaction History

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024
BUY
$0.2 - $0.57 $0 - $0
0 New
0 $0
Q3 2023

Oct 30, 2023
BUY
$0.33 - $0.73 $0 - $0
0 New
0 $0
Q3 2023

Oct 25, 2023
BUY
$0.33 - $0.73 $0 - $0
0 New
0 $0
Q2 2023

Aug 10, 2023
BUY
$0.59 - $1.32 $0 - $0
0 New
0 $0
Q1 2023

May 15, 2023
BUY
$0.5 - $0.83 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023
BUY
$0.39 - $17.12 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022
BUY
$0.82 - $13.44 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022
BUY
$0.81 - $2.72 $0 - $0
0 New
0 $0

Others Institutions Holding ACON

# of Institutions
2
Shares Held
165K
Call Options Held
0
Put Options Held
0
View Full List

About Aclarion, Inc.

ACON Quotes by TradingView
  • Ticker ACON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 7,821,520
  • Market Cap $1.49M
  • Description
  • Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical de...
More about ACON
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email